Indeed, the mRNA expression levels of CXCL2, TGFB1, CCL2, and IL1B were markedly increased in the breast cancer cell lines after treatment with Doxo and Abe (Supplementary Fig. 9a, b). The gene discussed is CXCL2; the disease is breast cancer.